# Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

> **NCT04197414** · — · RECRUITING · sponsor: **Yonsei University** · enrollment: 3000 (estimated)

## Conditions studied

- Prostate Cancer
- Renal Cell Cancer
- Bladder Cancer
- Ureter Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04197414
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-06
- **Primary completion:** 2029-11
- **Final completion:** 2029-12
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197414, "Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04197414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*